Special Considerations in Pulmonary Embolism Clot-in-Transit and Incidental Pulmonary Embolism

被引:11
作者
Kabrhel, Christopher [1 ]
Rosovsky, Rachel [2 ]
Garvey, Shannon [3 ]
机构
[1] Harvard Med Sch, Ctr Vasc Emergencies, Massachusetts Gen Hosp, Dept Emergency Med, Zero Emerson Pl,Suite 3B, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Med, Div Hematol, 55 Fruit St, Boston, MA 02114 USA
[3] Boston Univ, Sch Med, 72 E Concord St, Boston, MA 02118 USA
关键词
Pulmonary embolism; Clot-in-transit; Venous thromboembolism; RIGHT-HEART THROMBI; TISSUE-PLASMINOGEN ACTIVATOR; RIGHT ATRIAL THROMBUS; PROGNOSTIC-SIGNIFICANCE; VENOUS THROMBOEMBOLISM; FLOATING THROMBUS; ANTITHROMBOTIC THERAPY; EXTENDED TREATMENT; AMERICAN-COLLEGE; CANCER-PATIENTS;
D O I
10.1016/j.ccc.2020.02.008
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This article describes 2 relatively rare, but complex situations in pulmonary embolism (PE): clot-in-transit (CIT), incidental PE (IPE). CIT describes a venous thromboembolism that has become lodged in the right heart. CIT is associated with high mortality and presents unique challenges in management. Incidental PE (IPE) describes PE diagnosed on imaging performed for another indication. The treatment is complex because there is often a disconnect between the PE severity on imaging and lack of severity of the clinical presentation. We summarize the available literature and aid clinicians as they manage patients with PE across the clinical severity spectrum.
引用
收藏
页码:531 / +
页数:17
相关论文
共 74 条
[71]   Right heart thrombi in pulmonary embolism -: Results from the International Cooperative Pulmonary Embolism Registry [J].
Torbicki, A ;
Galié, N ;
Covezzoli, A ;
Rossi, E ;
De Rosa, M ;
Goldhaber, SZ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2245-2251
[72]   Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients [J].
van der Hulle, T. ;
den Exter, P. L. ;
Planquette, B. ;
Meyer, G. ;
Soler, S. ;
Monreal, M. ;
Jimenez, D. ;
Portillo, A. K. ;
O'Connell, C. ;
Liebman, H. A. ;
Shteinberg, M. ;
Adir, Y. ;
Tiseo, M. ;
Bersanelli, M. ;
Abdel-Razeq, H. N. ;
Mansour, A. H. ;
Donnelly, O. G. ;
Radhakrishna, G. ;
Ramasamy, S. ;
Bozas, G. ;
Maraveyas, A. ;
Shinagare, A. B. ;
Hatabu, H. ;
Nishino, M. ;
Huisman, M. V. ;
Klok, F. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (01) :105-113
[73]   Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism [J].
Weitz, J. I. ;
Lensing, A. W. A. ;
Prins, M. H. ;
Bauersachs, R. ;
Beyer-Westendorf, J. ;
Bounameaux, H. ;
Brighton, T. A. ;
Cohen, A. T. ;
Davidson, B. L. ;
Decousus, H. ;
Freitas, M. C. S. ;
Holberg, G. ;
Kakkar, A. K. ;
Haskell, L. ;
van Bellen, B. ;
Pap, A. F. ;
Berkowitz, S. D. ;
Verhamme, P. ;
Wells, P. S. ;
Prandoni, P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (13) :1211-1222
[74]   Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) [J].
Young, Annie M. ;
Marshall, Andrea ;
Thirlwall, Jenny ;
Chapman, Oliver ;
Lokare, Anand ;
Hill, Catherine ;
Hale, Danielle ;
Dunn, Janet A. ;
Lyman, Gary H. ;
Hutchinson, Charles ;
MacCallum, Peter ;
Kakkar, Ajay ;
Hobbs, F. D. Richard ;
Petrou, Stavros ;
Dale, Jeremy ;
Poole, Christopher J. ;
Maraveyas, Anthony ;
Levine, Mark .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (20) :2017-+